Luke J. Taus

448 total citations
9 papers, 107 citations indexed

About

Luke J. Taus is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luke J. Taus has authored 9 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luke J. Taus's work include CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Sociology and Education Studies (1 paper). Luke J. Taus is often cited by papers focused on CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Sociology and Education Studies (1 paper). Luke J. Taus collaborates with scholars based in United States, Sri Lanka and Hungary. Luke J. Taus's co-authors include Megan E. Cavanaugh, Mari Kuraguchi, Patrick H. Lizotte, Aaron Yang, Meghana Kulkarni, Troy A. Luster, Nathanael S. Gray, Pasi A. Jänne, Stephen Wang and Mark Bittinger and has published in prestigious journals such as Cancer Research, Cancer Letters and Biochimica et Biophysica Acta (BBA) - Bioenergetics.

In The Last Decade

Luke J. Taus

9 papers receiving 106 citations

Peers

Luke J. Taus

ONCOL

MB

PRM

IMMUN

CR

Shauna Blackmon United States

Annemieke De Wilde Belgium

Bianca J. Lee United States

Agnieszka Świątkowska United Kingdom

Marcin Dzienis Australia

Olga Ponomarova Ukraine

Joana L. Mora United States

Eugenia Ortega Spain

Xuya Cui China

Larry Ka-Yue Chow Hong Kong

Shauna Blackmon United States

Luke J. Taus

66 ×1.0

ONCOL

31 ×0.8

MB

31 ×0.8

PRM

29 ×1.4

IMMUN

19 ×1.1

CR

Citations per year, relative to Luke J. Taus Luke J. Taus (= 1×) peers Shauna Blackmon

Countries citing papers authored by Luke J. Taus

Since Specialization

Citations

This map shows the geographic impact of Luke J. Taus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke J. Taus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke J. Taus more than expected).

Fields of papers citing papers by Luke J. Taus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke J. Taus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke J. Taus. The network helps show where Luke J. Taus may publish in the future.

Co-authorship network of co-authors of Luke J. Taus

This figure shows the co-authorship network connecting the top 25 collaborators of Luke J. Taus. A scholar is included among the top collaborators of Luke J. Taus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke J. Taus. Luke J. Taus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Taus, Luke J., et al.. (2025). IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer. Cancers. 17(2). 290–290. 1 indexed citations

2.

Lizotte, Patrick H., Ruey‐Long Hong, Troy A. Luster, et al.. (2018). A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing. Cancer Immunology Research. 6(12). 1511–1523. 69 indexed citations

3.

Flores, Roberto E., Ashley K. Brown, Luke J. Taus, et al.. (2018). Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1859(9). 975–983. 20 indexed citations

4.

Lizotte, Patrick H., Troy A. Luster, Megan E. Cavanaugh, et al.. (2018). Abstract 4935: High-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of CTL antigen-specific tumor cell killing. Cancer Research. 78(13_Supplement). 4935–4935. 4 indexed citations

5.

Taus, Luke J., Roberto E. Flores, & Thomas N. Seyfried. (2017). Quantification of metastatic load in a syngeneic murine model of metastasis. Cancer Letters. 405. 56–62. 5 indexed citations

6.

Ivanova, Elena V., Magda Bahcall, Ting Chen, et al.. (2017). MA 07.12 Short-Term Culture of Patient Derived Tumor Organoids Identify Neratinib/Trastuzumab as an Effective Combination in HER2 Mutant Lung Cancer. Journal of Thoracic Oncology. 12(11). S1829–S1830. 3 indexed citations

7.

Taus, Luke J., et al.. (1991). Personality of semen donors and their social behaviour.. PubMed. 14(3). 173–83. 2 indexed citations

8.

Taus, Luke J.. (1977). [Sexological ambulatory care in Liberec].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(29-30). 915–6. 2 indexed citations

9.

Taus, Luke J. & Josef Stehlik. (1967). [The use of LSD in the psychotherapy of alcoholism].. PubMed. 63(2). 121–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact